FindTrial
Sign In

Association of hair loss with variation of blood components such as red blood cells, thyroid hormones in young women

Correlation of Anaemia, thyroid disorders with Telogen effluvium in reproductive age group females

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043154
Enrollment
115
Registered
2022-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L650- Telogen effluvium

Interventions

None listed

Sponsors

Shilpa A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All female patients of age 18-45 years with clinical diagnosis of Telogen effluvium Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: Patients with other causes of diffuse hair loss Patients with other comorbidities and on chemotherapy Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Relation of Anemia and Thyroid disorders with Telogen effluviumTimepoint: At baseline—

Secondary

MeasureTime frame
Estimate Hemoglobin and Thyroid hormone levelsTimepoint: At baseline—

Countries

India

Contacts

Public ContactShilpa A

Father muller medical college

dr_martisj@fathermuller.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026